- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
Population: Adults (18-64 years)
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- SARS-CoV-2
- Post COVID-19 condition
- Pharmacological intervention
- Antivirals
- Plitidepsin
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Rehabilitation
- Adults (18-64 years)
- General population
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Rehabilitation
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Antivirals
- Tecovirimat
- Adults (18-64 years)
- General population
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- mRNA-1769
- Adults (18-64 years)
- General population
- Outpatient clinic
- Non-hospital health centre
- STD/STI clinic
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- MVA-BN
- Adults (18-64 years)
- Elderly (≥65 years)
- SARS-CoV-2
- Post COVID-19 condition
- Pharmacological intervention
- Allopurinol
- Adults (18-64 years)
- People at high risk of STIs
- Men who have sex with men
- Primary care
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- Fragile population
- PrEP users
- People living with HIV
- Hospital
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- MVA-BN
- Adults (18-64 years)
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Dietary
- Lifestyle
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Lifestyle